|
SFRS13B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.941800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.869400E-01 |
| Normal-vs-Stage2 |
1.500210E-01 |
| Normal-vs-Stage3 |
3.689400E-01 |
| Normal-vs-Stage4 |
2.212200E-01 |
| Stage1-vs-Stage2 |
1.142780E-01 |
| Stage1-vs-Stage3 |
2.218600E-01 |
| Stage1-vs-Stage4 |
1.435390E-01 |
| Stage2-vs-Stage3 |
3.120100E-02 |
| Stage2-vs-Stage4 |
2.319800E-02 |
| Stage3-vs-Stage4 |
6.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.663800E-01 |
| Normal-vs-AfricanAmerican |
6.683800E-01 |
| Normal-vs-Asian |
6.126000E-01 |
| Caucasian-vs-AfricanAmerican |
4.582200E-01 |
| Caucasian-vs-Asian |
2.640800E-01 |
| AfricanAmerican-vs-Asian |
9.001800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.837000E-01 |
| Normal-vs-Female |
8.266200E-01 |
| Male-vs-Female |
1.342360E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.502000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.984600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.371600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.277400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.098400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.521600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.705200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.120400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.399600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.229600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.780400E-02 |
| Classical-VS-Follicular |
1.504210E-01 |
| Classical-VS-Other |
8.558000E-01 |
| Classical-VS-Normal |
9.185000E-01 |
| Tall-VS-Follicular |
8.696000E-03 |
| Tall-VS-Other |
4.704600E-01 |
| Tall-VS-Normal |
1.013370E-01 |
| Follicular-VS-Other |
5.495400E-01 |
| Follicular-VS-Normal |
2.725200E-01 |
| Other-VS-Normal |
8.006600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.547800E-01 |
| Normal-vs-N1 |
2.266400E-01 |
| N0-vs-N1 |
1.277990E-01 |
|
|
